Integrated CFPS Systems
Access to optimized E. coli, Wheat Germ, and Rabbit Reticulocyte Lysate systems for optimal protein folding and compatibility with diverse downstream assays.
Non-natural Amino Acid (nnAA) Incorporation via Cell-Free Protein Synthesis (CFPS) is a breakthrough technology that expands the genetic code, enabling the synthesis of proteins with novel functionalities beyond those achievable with the 20 canonical amino acids. By leveraging the open nature of CFPS systems, a genetically engineered orthogonal translation system is used to specifically incorporate an nnAA at a designated stop codon (TAG) within the target protein sequence.
CD Biosynsis offers a specialized CFPS for Non-natural Amino Acid Incorporation Service , providing the ideal platform for the rapid, site-specific production of novel functional proteins. Our service features high-yield CFPS extracts (E. coli, Wheat Germ, or Lysate systems) combined with our extensive library of over 50 orthogonal nnAAs . This approach eliminates issues of cell toxicity and transport limitations, accelerating the Design-Build-Test cycle for bioconjugates, novel enzymes, and structural probes . We guarantee site-specific incorporation and provide mandatory Mass Spectrometry (MS) verification for all custom nnAA-containing proteins.
Get a QuoteCore advantages of utilizing the open CFPS system for nnAA incorporation:
Expanding the genetic code for next-generation protein engineering and therapeutics:
Protein Bioconjugation (ADCs)
Incorporating functional handles (e.g., azide, alkyne) for highly selective Click Chemistry conjugation in Antibody-Drug Conjugates (ADCs) and protein labeling.
FRET & Structural Probes
Introducing fluorescent or spin labels at specific sites to monitor protein conformation, dynamics, and interaction in real time via FRET or EPR.
Enhanced Enzyme Catalysis
Introducing nnAAs with unique properties (e.g., enhanced acidity/basicity, metal binding) into enzyme active sites to improve catalytic efficiency or substrate specificity.
High-Throughput Screening
Rapidly producing large libraries of nnAA variants for directed evolution, aaRS engineering, and functional validation in a single day.
Our service provides flexible options and comprehensive technical support:
Integrated CFPS Systems
Access to optimized E. coli, Wheat Germ, and Rabbit Reticulocyte Lysate systems for optimal protein folding and compatibility with diverse downstream assays.
Extensive nnAA Library
Ready-to-use orthogonal systems for over 50 common nnAAs , including $p$-azido-L-phenylalanine, $p$-acetyl-L-phenylalanine, and various fluorophore-linked amino acids.
DNA Template Preparation
We perform the necessary site-directed mutagenesis (inserting the TAG codon) on your gene template and optimize the DNA template for maximal CFPS yield.
Mass Spectrometry QC
Mandatory MS analysis is performed to confirm full-length protein production and verify the exact mass shift corresponding to nnAA incorporation.
In-situ Functionalization
Optional post-translational modification or functionalization, such as Click Chemistry labeling of the nnAA handle, immediately after the CFPS reaction.
Our integrated process ensures the high-fidelity synthesis of your custom modified protein:
We provide essential assurance for your expanded genetic code projects:
What is the role of the orthogonal aaRS/tRNA pair?
The orthogonal aaRS is an enzyme that specifically recognizes only the non-natural amino acid and no natural amino acids. The orthogonal tRNA recognizes the stop codon (TAG) but is not recognized by any native aaRSs. This orthogonality ensures the nnAA is only incorporated at the TAG site.
How does CFPS compare to in vivo methods for nnAA incorporation?
CFPS is superior because it is an open system , allowing direct addition of nnAA without issues of cell membrane permeability or toxicity. This significantly increases incorporation efficiency and allows the use of chemistries that are impossible in living cells.
Can I incorporate nnAAs into a membrane protein?
Yes. Our CFPS service is highly effective for membrane proteins . We can incorporate nnAAs and express the protein directly into supplied liposomes or detergents within the lysate, overcoming the major challenge of membrane protein expression and folding in vivo.
How do you verify the incorporation efficiency?
We use Mass Spectrometry (MS) as the primary verification method. MS provides the exact molecular weight of the product, which is compared to the expected mass increase from the nnAA to confirm successful and full-length incorporation.
CRISPR-Cas9 technology represents a transformative advancement in gene editing techniques. The main function of the system is to precisely cut DNA sequences by combining guide RNA (gRNA) with the Cas9 protein. This technology became a mainstream genome editing tool quickly after its 2012 introduction because of its efficient, simple and low-cost nature.
The CRISPR gene editing system with its Cas9 version stands as a vital instrument for current biological research. CRISPR technology enables gene knockout (KO) through permanent gene expression blockage achieved by sequence disruption. Various scientific domains including disease modeling and drug screening employ this technology to study gene functions. CRISPR KO technology demonstrates high efficiency and precision but requires confirmation and verification post-implementation because unsatisfactory editing may produce off-target effects or incomplete gene knockouts which impact experimental result reliability. For precise and efficient Gene Editing Services - CD Biosynsis, Biosynsis offers comprehensive solutions tailored to your research needs.
The CRISPR-Cas9 knockout cell line was developed using CRISPR/Cas9 gene editing to allow scientists to remove genes accurately for research on gene function and disease models and pharmaceutical discovery. Genetic research considers this technology essential due to its high efficiency together with simple operation and broad usability.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
|
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.